Aurobindo Pharma gains on plan to expand product portfolio in the US

08 Jun 2017 Evaluate

Aurobindo Pharma is currently trading at Rs. 603.70, up by 5.65 points or 0.94% from its previous closing of Rs. 598.05 on the BSE.

The scrip opened at Rs. 603.00 and has touched a high and low of Rs. 606.75 and Rs. 598.75 respectively. So far 68301 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 895.00 on 06-Oct-2016 and a 52 week low of Rs. 504.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 606.75 and Rs. 576.00 respectively. The current market cap of the company is Rs. 35270.12 crore.

The promoters holding in the company stood at 51.87%, while institutions and non-institutions held 33.75% and 14.38% respectively.

Aurobindo Pharma is expanding its product portfolio in the US with high-value drugs. The portfolio mix is complemented with the introduction of high-value products and the future pipeline will include oncology, hormones, depot injections, inhalers, biosimilars, patches and films.

The addressable market for the company’s total 429 Abbreviated New Drug Applications (ANDAs) has been pegged at $91 billion, including $61 billion for the ANDAs which are under review and tentatively approved.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1091.75 8.15 (0.75%)
25-Apr-2024 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1510.20
Dr. Reddys Lab 6008.45
Cipla 1394.55
Zydus Lifesciences 932.00
Lupin 1594.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.